{"date":"2025-12-30","count":24,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7784-2025-12-30-2332-16dyq15","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"23:32:08","subject":"公告本公司董事會決議調整114年現金增資發行股數及募集金額","clause":"第9款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-12-30 23:32，「公告本公司董事會決議調整114年現金增資發行股數及募集金額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-12-30-1835-6puib9","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-12-30","time":"18:35:39","subject":"(補充公告) 本公司董事會決議通過將MMP-12抑制劑授權予關係人","clause":"第20款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-12-30 18:35，「(補充公告) 本公司董事會決議通過將MMP-12抑制劑授權予關係人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-12-30-1827-16vh0m5","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"18:27:56","subject":"公告取消本公司董事會決議辦理現金增資發行新股","clause":"第44款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-12-30 18:27，「公告取消本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-12-30-1736-1v75xhv","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-12-30","time":"17:36:53","subject":"公告本公司114年第一次私募普通股收足股款暨增資基準日","clause":"第51款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-12-30 17:36，「公告本公司114年第一次私募普通股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-12-30-1734-sdomm","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:34:22","subject":"公告本公司董事會推舉董事長","clause":"第6款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-12-30 17:34，「公告本公司董事會推舉董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-12-30-1733-1hu40k1","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:33:51","subject":"公告本公司薪酬委員會委員異動","clause":"第6款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-12-30 17:33，「公告本公司薪酬委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-12-30-1733-exr60a","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:33:33","subject":"公告本公司董事會決議通過參與不動產投標案","clause":"第44款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-12-30 17:33，「公告本公司董事會決議通過參與不動產投標案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-12-30-1732-1ewrl77","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:32:16","subject":"公告本公司設置審計委員會及第一屆審計委員會委員","clause":"第6款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-12-30 17:32，「公告本公司設置審計委員會及第一屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-12-30-1731-rzgerl","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:31:34","subject":"公告本公司成立審計委員會，監察人自然解任","clause":"第6款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-12-30 17:31，「公告本公司成立審計委員會，監察人自然解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-12-30-1730-f87r5g","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:30:38","subject":"公告本公司114年第二次股東臨時會通過解除新任董事競業禁止之限制","clause":"第22款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-12-30 17:30，「公告本公司114年第二次股東臨時會通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-12-30-1729-1x7mhb9","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:29:52","subject":"本公司114年第二次股東臨時會全面改選董事(含獨立董事)當選名單暨三分之一以上董事發生變動","clause":"第6款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-12-30 17:29，「本公司114年第二次股東臨時會全面改選董事(含獨立董事)當選名單暨三分之一以上董事發生變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-12-30-1726-1ye5yun","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"17:26:07","subject":"公告本公司114年第二次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-12-30 17:26，「公告本公司114年第二次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-12-30-1715-y7gzxf","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-12-30","time":"17:15:11","subject":"公告本公司董事會決議通過115年度對財團法人弘廬基金會之捐贈案","clause":"第43款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-12-30 17:15，「公告本公司董事會決議通過115年度對財團法人弘廬基金會之捐贈案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-12-30-1646-18bhctm","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-12-30","time":"16:46:26","subject":"公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果","clause":"第53款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-12-30 16:46，「公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-12-30-1639-7oiz22","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-12-30","time":"16:39:54","subject":"公告本公司受邀參加J.P. Morgan舉辦之第44屆Healthcare Conference法說會","clause":"第12款","fact_date":"2026-01-16","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-12-30 16:39，「公告本公司受邀參加J.P. Morgan舉辦之第44屆Healthcare Conference法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-12-30-1627-1fqkmsr","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-12-30","time":"16:27:31","subject":"澄清媒體報導","clause":"第53款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-12-30 16:27，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-12-30-1551-wew86v","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"15:51:41","subject":"公告本公司董事會通過副總經理晉升案","clause":"第11款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-12-30 15:51，「公告本公司董事會通過副總經理晉升案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-12-30-1544-1l248wr","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"15:44:29","subject":"公告本公司114年現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-12-30 15:44，「公告本公司114年現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-12-30-1517-1pzjlpi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"15:17:27","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-12-30 15:17，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-12-30-1455-zkvjm9","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-12-30","time":"14:55:09","subject":"公告本公司董事會決議實施第14次庫藏股買回","clause":"第35款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-12-30 14:55，「公告本公司董事會決議實施第14次庫藏股買回」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-12-30-1404-1mwy20b","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-12-30","time":"14:04:14","subject":"公告本公司開發之動物用骨關節炎長效止痛新藥「撲疼樂Bupanlar」向農業部防檢署申請動物新藥藥證審查。","clause":"第10款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-12-30 14:04，「公告本公司開發之動物用骨關節炎長效止痛新藥「撲疼樂Bupanlar」向農業部防檢署申請動物新藥藥證審查。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-12-30-1131-54swv6","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"11:31:41","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-12-29","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-12-30 11:31，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-12-30-0957-101vl0u","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-12-30","time":"09:57:53","subject":"澄清說明有關114/12/30工商時報及經濟日報報導","clause":"第51款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-12-30 09:57，「澄清說明有關114/12/30工商時報及經濟日報報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-12-30-0754-lg5av9","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-12-30","time":"07:54:54","subject":"代重要子公司Belite Bio, Inc公告完成現金增資(補充公告)","clause":"第44款","fact_date":"2025-12-30","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-12-30 07:54，「代重要子公司Belite Bio, Inc公告完成現金增資(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}